Adventures Through The Mind

Psychedelics for Chronic Pain | Dr. Alex Bekker - ATTMind 196

Apr 25, 2025
Dr. Alex Bekker, a Professor and Chairman of Anaesthesiology at Rutgers New Jersey Medical School, dives into the transformative potential of psychedelics in treating chronic pain. He discusses the critical differences between chronic and acute pain, emphasizing the role of maladaptive neuroplasticity. Dr. Bekker explains how psychedelics like ketamine and classic hallucinogens can disrupt chronic pain networks and foster new neural pathways. He advocates for a holistic approach, combining psychedelics with psychotherapy to enhance treatment outcomes.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Understanding Chronic Pain Mechanisms

  • Chronic pain results from peripheral and central sensitization, causing nerve damage that persists despite injury healing.
  • This leads to abnormal pain perception like hyperalgesia and allodynia due to disrupted neural pathways.
INSIGHT

Brain Remodeling in Chronic Pain

  • Chronic pain remodels the brain's default mode network, embedding pain perception into a person's resting mental state.
  • Psychedelic drugs can disrupt this network, allowing new, non-painful connections to form and reduce pain rumination.
INSIGHT

Limitations of Opioids for Chronic Pain

  • Opioids are effective for acute pain but ineffective and not recommended for chronic pain.
  • Chronic pain treatment relies on centrally acting drugs like amitriptyline and gabapentin targeting neural signaling, not peripheral inflammation.
Get the Snipd Podcast app to discover more snips from this episode
Get the app